Elisenda Alari‐Pahissa

Author

Universitat Pompeu Fabra ORCID

Also Known As

E. Alari‐Pahissa, Elisenda Alari-Pahisa, Elisenda Alari-Pahissa, Elisenda Alari‐Pahissa

Publications

421

Citations

H-Index

Concepts

All Affiliations

Universitat Pompeu Fabra Universitat Autònoma de Barcelona Instituto de Salud Carlos III Hospital Del Mar Universitat de Barcelona

About

Elisenda Alari‐Pahissa is an author at Universitat Pompeu Fabra specializing in immunology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	159
2	Immunology	7	7	159
3	Cell Biology	6	6	133
4	Allergy	1	1	17
5	Pathology	1	1	16

Elisenda Alari‐Pahissa

Publications

399

Citations

H-Index

Page 1

	Year	Citations
CD69 limits early inflammatory diseases associated with immune response to <i>Listeria monocytogenes</i> infection Javier Vega‐Ramos, Elisenda Alari‐Pahissa, Juana del Valle-Mendoza, Immunology and Cell Biology	2010	45
Antibody-Dependent NK Cell Activation Differentially Targets EBV-Infected Cells in Lytic Cycle and Bystander B Lymphocytes Bound to Viral Antigen–Containing Particles María López‐Montañés, Elisenda Alari‐Pahissa, Jordi Sintes, The Journal of Immunology	2017	36
Adaptations of Natural Killer Cells to Self-MHC Class I Stéphanie Bessoles, Camille GrandclÃ©ment, Elisenda Alari‐Pahissa, Frontiers in Immunology Autoimmune DiseaseImmune Cell DevelopmentMedicineImmunologyImmunologic Mechanism	2014	34
Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR Laura Notario, Elisenda Alari‐Pahissa, Almudena Albentosa, Leukemia High ProliferationImmunologyImmunologic MechanismCellular Immune ResponseMedicine	2018	32
Structural and Functional Characterization of a Novel Nonglycosidic Type I NKT Agonist with Immunomodulatory Properties Jérôme Kerzerho, Esther Dawen Yu, Carolina Barra, The Journal of Immunology Nkt AgonistInflammatory Lung DiseaseLung InflammationImmune ManipulationImmunology	2012	26
Impact of cytomegalovirus infection on B cell differentiation and cytokine production in multiple sclerosis Ana Zabalza, Andrea Vera, Elisenda Alari‐Pahissa, Journal of Neuroinflammation	2020	26
Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the ‘hygiene hypothesis’? Elisenda Alari‐Pahissa, Antía Moreira, Ana Zabalza, European Journal of Neurology	2018	25
CD69 Does Not Affect the Extent of T Cell Priming Elisenda Alari‐Pahissa, Laura Notario, Elena Lorente, PLoS ONE Adaptive Immune SystemT Cell PrimingImmunologyDc MaturationExpression Kinetics	2012	23
Adaptive Features of Natural Killer Cells in Multiple Sclerosis Antía Moreira, Elisenda Alari‐Pahissa, Elvira Munteis, Frontiers in Immunology	2019	23
Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression Anna Rea, Sara Santana-Hernández, Javier Rodríguez Villanueva, Nature Immunology	2025	23

Page 1